UnitedHealth Group stands out as a solid investment choice amidst financial uncertainty. With an equity beta of 0.67, it offers a stable investment with growth potential. The company, driven by ...

We recently compiled a list of the 10 Best Low Risk Stocks To Buy in 2025. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against the other ...

A court-appointed special master has recommended the dismissal of a 14-year-old whistleblower lawsuit against UnitedHealth ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

President Donald Trump's nominee to lead the agency overseeing Medicare should divest financial ties to healthcare and ...

The civil fraud case against UnitedHealth Group, the nation’s largest Medicare Advantage insurer, was filed in 2011 by whistleblower Benjamin Poehling, a former company employee. The DOJ took over the ...

The Centers for Medicare & Medicaid Services (CMS) wiped away the agency’s stated intentions for the future of Medicare ...

Daytime television inundates American seniors with advertisements for UnitedHealthcare’s (“UHC”) Medicare Advantage Plans. On its website, UHC ...

Two of the Dow Jones Industrial Average's 30 components make for no-brainer buys, while another brand-name member continues ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

It has been 10 years since the first biosimilar was approved by the FDA. The grades on how the market for biosimilars has ...

After 14 years, thousands of pages of legal documents and depositions, a whistleblower case against Minnesota-based ...